OHSU research led by Bahareh Ajami, Ph.D., published in Nature Neuroscience, on a previously unknown group of immune cells in the brains of people with Alzheimer’s disease is covered in the German publication Die Sachen News

Earth.com reports on OHSU research that shows that the MYC protein, which has long been known to drive cancer growth and development, also helps cancer survive DNA-damaging treatments by repairing the DNA in cancer cells. Rosalie Sears, Ph.D., says, “These insights advance our understanding of MYC’s function beyond transcriptional regulation, highlighting additional contributions to MYC-driven oncogenesis and resistance to cellular stress and DNA-damaging therapies that could be critical for patient outcomes”

Healthcare Innovation reports on Project ECHO, a telementoring and capacity-building program that is a key part of Oregon’s rural health efforts. Maggie McLean McDonald, M.P.H., says, “We were very fortunate to be included in Immediate Impact Awards in Oregon, and it was said by OHA that we were chosen because of our ability to deliver programs and also the evaluation support that we would be able to give in year one and year two.”

A story in Yahoo, about a neurological condition called locked-in syndrome quotes Betts Peters, Ph.D., “It’s about being able to tell your spouse that you love them, about being able to tell a story to your kids or ask questions, or just talk with your friend who’s come over to visit.”

A story in Popular Mechanics about a neurological condition called locked-in syndrome quotes Betts Peters, Ph.D., “It’s about being able to tell your spouse that you love them, about being able to tell a story to your kids or ask questions, or just talk with your friend who’s come over to visit.”

Stuart Ibsen, Ph.D., talks about an OHSU study that established a rapid blood test to differentiate pancreatic cancer from other pancreatic conditions. Ibsen says, “The technology that we are demonstrating here allows us to really quickly recover these nanoparticles and look at the cancer-related biomarkers that they’re carrying”

Diagnostics World interviews Stuart Ibsen, Ph.D., about an OHSU study that established a rapid blood test to differentiate pancreatic cancer from other pancreatic conditions. Ibsen says, “The technology that we are demonstrating here allows us to really quickly recover these nanoparticles and look at the cancer-related biomarkers that they’re carrying.”

RTT News covers an OHSU study that found that state-level abortion bans were associated with a reduction in evidence-based medical care for miscarriage management. Maria Rodriguez, M.D., says, “These are very real and dangerous clinical implications for the hundreds of thousands of women experiencing miscarriages annually”

Inside Precision Medicine reports on OHSU research that shows that the MYC protein, which has long been known to drive cancer growth and development, also helps cancer survive DNA-damaging treatments by repairing the DNA in cancer cells. Rosalie Sears, Ph.D., says, “These insights advance our understanding of MYC’s function beyond transcriptional regulation, highlighting additional contributions to MYC-driven oncogenesis and resistance to cellular stress and DNA-damaging therapies that could be critical for patient outcomes”:

Becker’s Hospital Review mentions OHSU’s Vista Pavilion in a roundup of health system projects in 2026 worth $500 million or more.